Compare MCK & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCK | UBS |
|---|---|---|
| Founded | 1833 | 1862 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 120.6B |
| IPO Year | N/A | N/A |
| Metric | MCK | UBS |
|---|---|---|
| Price | $823.39 | $42.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $882.69 | N/A |
| AVG Volume (30 Days) | 848.8K | ★ 1.9M |
| Earning Date | 02-04-2026 | 02-03-2026 |
| Dividend Yield | 0.40% | ★ 1.72% |
| EPS Growth | 66.19 | ★ 84.33 |
| EPS | ★ 32.12 | 2.21 |
| Revenue | ★ $387,094,000,000.00 | $48,193,000,000.00 |
| Revenue This Year | $14.87 | $4.87 |
| Revenue Next Year | $8.32 | $3.54 |
| P/E Ratio | $25.34 | ★ $18.63 |
| Revenue Growth | ★ 17.23 | 2.09 |
| 52 Week Low | $558.13 | $25.75 |
| 52 Week High | $895.58 | $43.76 |
| Indicator | MCK | UBS |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 72.39 |
| Support Level | $793.92 | $38.33 |
| Resistance Level | $826.00 | $43.76 |
| Average True Range (ATR) | 17.23 | 0.54 |
| MACD | -5.04 | 0.52 |
| Stochastic Oscillator | 31.66 | 84.32 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.